Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma

Published:2020-11 Issue:1 Volume:10 Page:79-86
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med.

Author:

Dizman Nazli¹²^ORCID,Hsu JoAnn¹,Bergerot Paulo G.¹,Gillece John D.³,Folkerts Megan³,Reining Lauren³,Trent Jeffrey⁴,Highlander Sarah K.³,Pal Sumanta K.¹^ORCID

Affiliation:

1. Department of Medical Oncology and Experimental Therapeutics City of Hope Comprehensive Cancer Center Duarte CA USA

2. Department of Internal Medicine Yale New Haven Hospital, Yale University Medical School New Haven CT USA

3. Pathogen and Microbiome Division Translational Genomics Research Institute North Flagstaff AZ USA

4. Translational Genomics Research Institute Phoenix AZ USA

Funder

Pfizer

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3569

Reference23 articles.

1. Systemic Therapy for Metastatic Renal-Cell Carcinoma

2. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

3. Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

4. Biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A+Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).

5. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy efficacy and toxicity: Reviewing the evidence behind patient implementable strategies;European Journal of Cancer;2024-09

2. Diet-Driven Alterations in Gut Microbiota and their Implications for Cancer Therapy: A Review;Journal of Young Pharmacists;2024-08-23

3. The gut microbiome and dietary metabolites in the treatment of renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-08

4. Targeting gut and intratumoral microbiota: a novel strategy to improve therapy resistance in cancer with a focus on urologic tumors;Expert Opinion on Biological Therapy;2024-06-24

5. Biomarqueurs émergents dans les cancers du rein à cellules claires;Bulletin du Cancer;2024-06